Egetis Therapeutics AB (publ)
STO:EGTX
Egetis Therapeutics AB (publ)
STO:EGTX
Price:
5.77
SEK
-1.54%
Market Cap:
kr2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
SE |
|
Ecofin US Renewables Infrastructure Trust PLC
LSE:RNEW
|
UK |
|
E
|
Elopak ASA
OSE:ELO
|
NO |
|
Storebrand ASA
OSE:STB
|
NO |
|
Humbl Inc
OTC:HMBL
|
US |
|
A
|
Ascopiave SpA
DUS:AVA
|
IT |
|
Ocugen Inc
NASDAQ:OCGN
|
US |
|
M
|
Manz AG
XETRA:M5Z
|
DE |
|
J
|
Jaeren Sparebank
OSE:JAREN
|
NO |
|
JCET Group Co Ltd
SSE:600584
|
CN |
|
Beacon Roofing Supply Inc
NASDAQ:BECN
|
US |
|
Z
|
Zhongnanhong Culture Group Co Ltd
SZSE:002445
|
CN |
|
T
|
Tern Properties Co Ltd
HKEX:277
|
HK |
|
S
|
Shanghai Anlogic Infotech Co Ltd
SSE:688107
|
CN |
|
Z
|
Zanlakol Ltd
TASE:ZNKL
|
IL |
|
Lightbridge Corp
NASDAQ:LTBR
|
US |
|
E
|
ERG SA
WSE:ERG
|
PL |
|
EVIO Inc
OTC:EVIO
|
US |
|
Fujian Funeng Co Ltd
SSE:600483
|
CN |
|
S
|
Summa Linguae Technologies SA
WSE:SUL
|
PL |
|
I
|
Intellivate Capital Ventures Ltd
BSE:506134
|
IN |
|
RITES Ltd
NSE:RITES
|
IN |
|
V
|
Vexilla Viet Nam Group JSC
VN:SVN
|
VN |
|
Sobr Safe Inc
NASDAQ:SOBR
|
US |
Multiples-Based Value
The Multiples-Based Value of one
EGTX
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 5.77 SEK,
Egetis Therapeutics AB (publ)
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EGTX Multiples-Based Value
LOCKED
Multiples Across Competitors
EGTX Competitors Multiples
Egetis Therapeutics AB (publ) Competitors
Egetis Therapeutics AB (publ) Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Egetis Therapeutics AB (publ)
STO:EGTX
|
2.3B SEK | 36.5 | -6.7 | -6.2 | -6.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD | 6.1 | 88.8 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.7 | 13.2 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.3 | 39.7 | 43 | 43.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
